BioPorto Diagnostics (OMX: BIOPOR)

Last close As at 18/03/2024

1.57

0.02 (1.29%)

Market capitalisation

525m

Edison Investment Research is terminating coverage on BioPorto Diagnostics. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Latest Insights

View More

Healthcare | Flash note

BioPorto Diagnostics — Key leadership changes announced

Healthcare | edison tv

BioPorto – executive interview

Share Price Performance

Financials

Edison Investment Research is terminating coverage on BioPorto Diagnostics. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Thematics

thematic

Healthcare

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

volition01

thematic

Healthcare

VolitionRx – Decoding the DNA of cancer 

thematic

Healthcare

ASCO 2023 key takeaways

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free